search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS EU classifies TiO2


The EU moved last month to classify TiO2


as a category 2


suspected carcinogen by inhalation under its classifi- cation, labelling and packaging (CLP) regulation of substances and mixtures. The move follows an opinion from the Risk Assessment Committee (RAC) of the European Chemicals Agency (ECHA). This has been consistently challenged by the Titanium Dioxide Manufacturers Association (TDMA), which argues that it was not based on new scientific evidence or understanding of potential harms and is contrary to available data of more than 24,000 workers demonstrating no link


inhalation carcinogen to “powder TiO2 as an and


mixtures placed on the market in powder form containing 1% or more of TiO2


New CLP rules apply to substances/mixtures containing TiO2


from 2021


between exposure and cancer in humans. While TDMA acknowl- edges that the EU has attempted to limit the classi- fication of TiO2


to powders —the regulatory text refers


which is in the form of, or incorporated in, particles” — it said the text introduces several new concepts and terms without providing meaningful definitions or interpretative guidelines. It predicted this will open the door to various interpretations. “The EU’s decision will apply on 9 September 2021 and the time until then will be needed to attempt to address ambiguities created by the text,” according to the association. � www.echa.europa.euwww.tdma.info


Foster teams up with LioChem


US-based Foster Corporation, which specialises in plastics for medical device and pharmaceutical applications, has formed a partnership with masterbatch and colorant firm LioChem. The company said the arrangement will allow it to use LioChem’s capabilities to


augment its own capacity and to extend the colour matching expertise and speed of service it offers. Terms were not disclosed. LioChem supplies its custom formulated Lioplax MD range of colour masterbatch products for the medical device market. � www.fostercomp.com


Ampacet acquires LIAD


Masterbatch producer Ampacet has acquired LIAD Weighing & Control Systems, a maker of feeders, blenders and real-time colour manage- ment technologies for the plastics industry based in Israel. Founded in 1979, LIAD has developed an in-line, multi-probe spectrometer for continuous and real- time colour quality measur- ing. It also manufactures single-component gravi- metric feeders for injection moulding machines. Ampacet CEO and


President Alvaro Mendoza said the company “is entering into a new era of delivering holistic solutions to our customers and preparing the stage to enter into new markets with a different value proposi- tion”. It has established a new business unit — CISys- tems Colour Integration — to distribute LIAD’s products in North America. � www.ampacet.com � www.liad.co.il


Custom medical colours


Techmer PM and BASF are now offering Ultrason S, P and E (PSU, PPSU and PESU) polyarylsulphone medical grades in custom colours in the US.


Used to produce products such as medical devices and sterilisa-


tion trays, all grades comply with USP Class V or VI and ISO 10993 requirements. Small volume orders will be supplied through Techmer PM’s Hifill brand; larger volumes will be supplied directly by BASF. According to Hung Pham, Ultrason Strategic Business Manager at


Techmer PM and BASF are offering custom coloured Ultrason grades in US


6 COMPOUNDING WORLD | March 2020


BASF, the new grades will help customers evaluate and determine suitability faster by removing the custom colour blending process. � www.basf.com � www.techmerpm.com


www.compoundingworld.com


IMAGE: BASF


IMAGE: SHUTTERSTOCK


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68